Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.19.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Income Statement [Abstract]    
Revenues $ 3,515,815 $ 2,082,950
Cost of revenues 1,254,790 888,869
Gross profit 2,261,025 1,194,081
Operating expenses:    
Personnel 673,375 184,671
Marketing and promotion 118,899 51,761
General and administrative 1,691,032 1,279,291
Total operating expenses 2,483,306 1,515,722
Operating income (222,881) (321,641)
Non-operating income (expenses):    
Interest expense (1,940,547) (316,261)
Interest income 282,409 19,834
Equity in earnings of investments 1,958,407
Loss on debt settlements (1,213,841)
Total non-operating income (expenses) 300,269 (1,510,268)
Net income (loss) 77,988 (1,831,909)
Net income (loss) attributable to noncontrolling interests 101,199 63,233
Net income (loss) attributable to MariMed Inc. $ (23,211) $ (1,895,142)
Net income (loss) per share $ (0.000) $ (0.011)
Weighted average common shares outstanding 212,034,324 178,914,829